BRYAN CAVE LEIGHTON PAISNER LLP for THE ENDOCRINE SOCIETY
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 1894, S. 769, the Medicare Fracture Prevention and Osteoporosis Testing Act Minority Health Disparities (obesity and diabetes) H. R. 3200, America's Affordable Health Choices Act of 2009, Osteoporosis prevention provisions, provider workforce provisions S. 1796, Americas Healthy Future Act of 2009, Osteoporosis prevention provisions, provider workforce provisions H.R. 3962, Affordable Health Care for America Act, Osteoporosis prevention provisions, provider workforce provisions H.R. 3590, The Patient Protection and Affordable Care Act, Osteoporosis prevention provisions, provider workforce provisions HR 4872, Health Care and Education Reconciliation Act of 2010 H.R. 4190, S. 2828 Endocrine Disruptor Screening Enhancement Act of 2010 HR 5210, Endocrine Disrupter Screening Enhancement Act of 2010 S. 3209, Safe Chemicals Act of 2010
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM APPLEGATE | — |
| CHRISTOPHER RORICK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.